Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  ANTA PHAR       

 SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Company
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on developing and commercializing products to treat autoimmune diseases. The company's primary product candidate, blisibimod, targets elevated levels of B-cell activating factor, or BAFF, which has been associated with a... 
Sector
Biotechnology
Calendar
05/01Earnings Release
Surperformance© rating of ANTA PHAR
Trading Rating : Investor Rating :
More about the company
Chart ANTA PHAR
Duration : Period :
ANTA PHAR Technical Analysis Chart | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 4,00 M
EBIT 2014 -42,1 M
Net income 2014 -43,6 M
Debt 2014 -
Yield 2014 -
Sales 2015 6,00 M
EBIT 2015 -43,3 M
Net income 2015 -44,8 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 14,1x
Capi. / Sales 2015 9,38x
Capitalization 56,3 M
More Financials
Latest news on ANTA PHAR
04/10 ANTHERA PHARMACEUTICALS : Announces Personnel Changes
04/02 ANTHERA PHARMACEUTICALS : Reports Personnel Changes
03/31 ANTHERA PHARMACEUTICALS : Announces Personnel Changes
03/28 ANTHERA PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL COND..
03/12 ANTHERA PHARMACEUTICALS INC : Anthera Pharmaceuticals Reports 2013 Fourth Quarte..
03/12 ANTHERA PHARMACEUTICALS : Results of Operations and Financial Condition, Non-Rel..
02/09 ANTHERA PHARMACEUTICALS INC : Anthera Pharmaceuticals CEO Paul Truex to Present ..
02/04 ANTHERA PHARMACEUTICALS INC : Anthera Pharmaceuticals CEO Paul Truex to Present ..
01/30 ANTHERA PHARMACEUTICALS INC : Anthera Pharmaceuticals to Present at Leerink Swan..
01/28 FLG Partners Announces Chris Lowe as a New Partner
2013 ANTHERA PHARMACEUTICALS INC : FILES (8-K) Disclosing Change in Directors or Prin..
2013 ANTHERA PHARMACEUTICALS INC : FILES (8-K) Disclosing Change in Directors or Prin..
More news
Comments 
Advertisement
Income Statement Evolution
ANTA PHAR : Income Statement Evolution
More Financials
EPS Revisions
ANTA PHAR : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF